Atrium Health Opens Preventive Vaccine Clinical Trial For COVID-19
Atrium Health will participate in a phase 3 COVID-19 investigational vaccine clinical trial in the fight against COVID-19. The clinical trial will test the safety, immunogenicity, and effectiveness of NVX-CoV2373, developed by U.S. company Novavax, Inc.
